Broad-spectrum drug screening requires that all relevant substances be isolated, detected, and identified, regardless of their structure and/or polarity. To this end, systematic solid-phase extraction (SPE) approaches for drug isolation from biological fluids are required. Because speed and cost effectiveness are key issues in analytical toxicology, we have evaluated a disc-format extraction device for this purpose and compared the latter with an existing packed-bed column-format method. The discs were SPEC.PLUS.C18AR/MP3 cartridges with 10-mL solvent reservoirs, providing hydrophobic and cation exchange interactions. Blank human urine was spiked at 2 pg/mL with a selection of acidic, neutral, and basic drugs representing a variety of relevant drug classes. Urine specimens (2 mL) were diluted with 2 mL 0.1M phosphate buffer (pH 5.0) and then applied to the preconditioned disc. Washing was done with 1 mL water. Acidic and neutral drugs were eluted with 1 mL ethyl acetate/acetone (1:1), and basic drugs were eluted with I mL ammoniated ethyl acetate. The eluates were collected separately, evaporated down to about 0.1 mL, and analyzed by gas chromatography-flame-ionization detection to check cleanliness, recoveries, and reproducibilities. The discs showed good extraction properties for all drugs and were easy to handle. Recoveries were 75-100% with coefficients of variation of around 5 %. The resulting eluates showed only a few matrix interferences. As compared to our standard SPE method with packed-bed columns, the disc procedure allowed reductions in elution volumes and total processing time of approximately 60-65%.
Introduction
In recent years, solid-phase extraction (SPE) has become the technique of choice for the isolation and concentration of potentially harmful substances in clinical and forensic toxicology. Many solid phases for the extraction of toxicologically relevant biofluids are now available in cartridge form with bed masses of * Presented in pad at the SOFT-TJAFT 1998 Meeting, Albuquerque, New Mexico, October 5-9, 1998 . Author In whom correspondence should be addressed. Dr. Rokus A. 100-200 mg present in a packed column and with solvent reservoirs on the order of 3-10 mL In addition to its many applications for the analysis of individual drugs or drug classes, SPE has also proven to be suitable for broad-spectrum drug screening. Yet, in order to isolate all relevant substances, regardless of their structure and/or polarity, we developed a systematic SPE approach for drug isolation from biological fluids based on a column that gave mixed-mode retention. Hydrophobic and cation exchange interaction mechanisms provided good recoveries for a wide variety of acidic, neutral, and basic drugs, and the resulting extracts were rather clean in subsequent gas chromatographic (GC) and high-performance liquid chromatographic (HPLC) analyses (1) (2) (3) .
A novel advancement in SPE occurred with the introduction of SPE materials in disc format (4) . Discs usually have a thickness of 0.5-1 mm and bed masses of 15-70 mg, and they overcome several disadvantages of packed-bed SPE devices, such as restricted flow rates and channeling. Moreover, discs reportedly allow faster sample processing, require smaller solvent volumes, retain analytes efficiently, and minimize nonspecific adsorption (5, 6) . Because these factors are key issues in analytical toxicology, we have evaluated SPEC discs for broadspectrum drug screening in urine.
Experimental

Materials
All drugs were of pharmacopoeial quality and obtained from commercial suppliers. Organic solvents were of reagent grade (LabScan, Dublin, Ireland), and 33% ammonia was of extra pure quality (Merck, Darmstadt, Germany). All other chemicals were of analytical grade (Merck). Stock solutions of individual drugs were prepared by dissolving appropriate amounts in methanol/ethyl acetate (1:1) to obtain concentrations of 100 pg/mL. The chromatographic standard (CS) was prazepam, which was dissolved in ethyl acetate to give a solution of 40 pg/mL. Ammoniated ethyl acetate (2%) was made daily by adding 1 mL ammonia to 49 mL ethyl acetate. The mixture was sonicated for 1 rain before use.
Human urine was obtained from drug-free volunteers in the laboratory. Specimens were spiked with individual drugs, usually at concentrations of 2 pg/mL. Alternatively, specimens were spiked with reference mixtures M1 and M2. The composition of these mixtures and the approximate GC retention times of the drugs are given in Table I . The mixtures were made as described for the stock solutions of individual drugs at concentrations of 100 pg/mL for each drug.
Extraction discs
SPE was performed on SPEC.PLUS.C 18AR/MP3 discs (ANSYS Diagnostics, Inc., Lake Forest, CA) having a bed mass of 70 mg and a specimen reservoir of 10 mL. This glass fiber-based multimodal product is embedded with surface-modified silica and contains two discs. The top disc is C18AR and the lower disc is MP3 (a mixture of a strong cation exchanger and a slightly polar moiety).
Instrumentation
A Baker-10 SPE vacuum manifold system was from J.T. Baker (Deventer, The Netherlands). The sonic bath was a type SC-200-202 (Sonicor, Farmingdale, NY). The centrifuge was a Mefuge 1.0 from Heraeus Sepatech (Osterode/Harz, Germany).
Analysis of the SPE fractions was performed on a HewlettPackard (Avondale, PA) 5890 series II equipped with a 7671A automatic sampler, a 5890A GC terminal, and a flame-ionization detector (FID). The column was a 30-m HP-1 (cross-linked methyl silicone) fused-silica wide-bore capillary column (0.53-mm i.d., 0.88-pro film thickness). The operation conditions were initiated at 170~ with a 2-rain hold. The oven was then programmed from 170~ to 270~ at 7~
The final temperature was held for 5 rain. Injector and detector temperatures were 260~ and 280~ respectively. Injections were done in the splitless mode. The helium carrier gas flow rate was 10 mL/min, the hydrogen flow rate was 3.5 mL/min, and the air flow rate was 110 mL/min. Injection volumes were 1 pL.
Specimen pretreatment
To 2 mL urine (spiked at 2 pg/mL for each drug) was added 2 mL 0.1M sodium phosphate buffer, pH 5.0 (PB). After being vortex mixed for 30 s, the specimens were centrifuged at 1500 xg for 2 min. 
Disc extraction procedure
The extractions were performed on the vacuum station and consisted of the following steps.
1. Conditioning. Pass I mL methanol through the disc. Pass 1 mL 0.1M sodium phosphate buffer (pH 5.0) through the disc. Do not let the disc run dry during these steps. 
Calculations
Calibration curves of individual drugs were made from solutions in ethyl acetate to which prazepam had been added at a concentration of 2 pg/mL. Drug concentrations ranged from 0.1 to 5.0 pg/mL. Peak-height ratios of drugs to prazepam were measured, and the calibration curves were generated from least-squares linear regressions. The latter were used to calculate the absolute recoveries of the individual drugs in the disc extraction from urine.
Results and Discussion
Calibration curves for the individual drugs were linear over the range studied and showed correlation coefficients of at least 0.9900. Peak-height ratios were preferred over peak-area ratios because the latter were sometimes slightly affected by the nearby elution of small matrix interferences. In general, the discs were easy to handle and clogging never occurred. The passage of liquid through the discs was adequate under gravity conditions, but occasionally some light vacuum was needed when the specimen was applied. Between discs, differences in flow velocities were in the order of 20% or less, which can be considered acceptable.
The conditions chosen proved to be quite satisfactory in that relatively clean chromatograms and good recoveries were obtained for all drugs tested. The latter are summarized in Table  II . All substances in M1 gave recoveries in the 90-100% range. For the more basic drugs in M2 the recoveries appeared to be somewhat lower, between 70 and 90%. It may be noted that the weakly basic drugs methaqualone and diazepam eluted almost exclusively in the A fraction, because of the pH of 5.0. In earlier work (1-3) on packed columns, we eluted the A/N fraction under more acidic conditions (pH 3.3), under which these weakly basic drugs showed a tendency to partly appear in the A/N fraction and partly in the B fraction, the overall recovery usually being close to 100%. Recovery percentages for some additional drugs were as follows (n = 2): amphetamine 72, methamphetamine 78, MDMA 89, fluoxetine 82, midazolam 96, oxazepam 94, hydrocodone 85, nortriptyline 81, and morphine 72. These figures indicate that a wide variety of toxicologically relevant structures are well retained by the discs and that they can be rapidly eluted as well.
The cleanliness of the extracts can be judged from the chromatograms in Figures 1 and 2 . FID was chosen as a universal detection mode to specifically detect matrix and impurity interferences. Eluate A/N shows some matrix interference between 8.5 and 9.8 rain. The two larger peaks at 8.9 and 9.1 rain are due to caffeine and its major metabolite in the urine of the Table I .
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Journal of Analytical Toxicology, Vo [. 24, March 2000 volunteer. Yet, the latter do not interfere with the recognition in the peaks of pentobarbital and secobarbital. The chromatogram of eluate B of blank urine is free of interfering peaks. Figures 3 and 4 show chromatograms of urine spiked with M1, whereas Figure 5 features a chromatogram of urine spiked with M2. It can be noted that excellent chromatograms were obtained with high separation efficiencies. Column and detector performances remained virtually unchanged for a period of three months of daily use.
In an attempt to get further insight in the adsorption and desorption kinetics during the disc extraction process, additional experiments were carried out in which the elution steps were changed as follows: elution A/N was performed with 2 x 0.5 mL EA/AC, and the eluates were collected and analyzed separately. Elution B was performed with 2 x 0.5 mL EA/AM and the eluates were collected and analyzed separately.
The recoveries are given in Table III . A number of important conclusions can be made. 1. A further reduction of the elution volumes to 0.5 mL is not feasible on the 10-mL format 70-mg column. 2. Carrying out the elution in two steps of 0.5 mL does not noticeably increase the recoveries of the basic drugs. 3. The desorption kinetics of the basic drugs are slower than for the acidic and neutral drugs. The recoveries of the former may be boosted to almost 100% with an elution volume of more than 1 mL for the B fraction. 4. Because no drugs were found in the run-through of the urine specimens (details not shown), the adsorption kinetics appear to be quite fast.
As compared to our initial SPE procedure on packed-bed columns (2), the disc procedure as presented here and using single elution volumes of 1 mL for each fraction allowed a reduction of elution volumes and total processing time by some 60-65%. As can be seen in Table IV , the biggest gains are in the conditioning and elution steps. An added advantage of the disc method is that it no longer uses chlorinated solvents.
In conclusion, the SPEC discs proved to be very suitable for broad-spectrum drug screening in urine. Good recoveries were obtained for a selection of acidic, neutral, and basic drugs representing relevant drug classes. The resulting extracts were quite clean upon GC-FID analysis. The biggest advantage of the disc procedure for analytical toxicology was its speed. The total time to process 10 specimens through the extraction and evaporation procedure was in the order of 20 min, whereas it took 55 min in our packed-bed column procedure. Moreover, the disc procedure required only 3 mL of organic solvents versus 8 mL with the packed-bed method.
